Trending News
News
News
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
News
Embryonic gene Nanog reverses aging in adult stem cells
Discovery may lead to treatments for Alzheimer's and other age-related disorders.
News
Ear test may identify autism risk
Researchers have identified an inner ear deficiency in children with autism that may impact their ability to recognize speech. The findings, which were published in the journal Autism Research, could ultimately be used as a way to identify children at risk for the disorder at an early age.
News
Among the oldest adults, poor balance may signal higher risk for dementia
The number of people living well into their 90s is projected to quadruple by 2050. By mid-century, nearly 9 million people will be 90-years-old or older. In a first-of-its-kind study published in the Journal of the American Geriatrics Society, researchers from the University of California at Irvine examined whether four different measures of poor physical performance might be linked to increased dementia risk for people aged 90 and older.
News
Relypsa Acquired for $1.53Bn
Galenica is to acquire Relypsa, following company agreements, to reinforce its Vifor Pharma business unit.
News
Evoke Pharma EVK-001 Candidate Fails Trial
Evoke Pharma's lead candidate EVK-001 has failed the phase III clinical trial after failing to meet its endpoint at week 4.
News
Childhood Cancer Initiative Granted $2.5M
St. Baldrick's Foundation funds Treehouse Childhood Cancer Initiative with $2.5 million grant
News
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
News
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
News
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Advertisement